COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

29,906 Articles (22,039 medRxiv, 7,867 bioRxiv)

Most recent first Previous |  Page 13: Articles 121-130  | Next

Effect of cysteine oxidation in SARS-CoV-2 Spike protein on its conformational changes: insights from atomistic simulations
Ghasemitarei, M., Taeb, H., Ghorbi, T., Yusupov, M., Ala-Nissila, T., Bogaerts, A.
10.1101/2024.10.24.620034 — Posted: 2024-10-25
The effectiveness of medical face masks and respirators in reducing SARS-CoV-2 transmission in community settings: a scoping review
Vardavas, C. I., Marou, V., Aslanoglou, K., Manta, A., Lagou, I., Plyta, Z., Leonardi-Bee, J., Lamb, F., Cenciarelli, O., Baka, A.
10.1101/2024.10.23.24315907 — Posted: 2024-10-24
SARS-CoV-2 within-host population expansion, diversification and adaptation in zoo tigers, lions and hyenas
Bashor, L., Gallichotte, E. N., Galvan, M., Erbeck, K., Croft, L., Stache, K., Stenglein, M. D., Johnson, J. G., Pabilonia, K., VandeWoude, S.
10.1101/2024.10.24.620075 — Posted: 2024-10-24
T cell epitope mapping reveals immunodominance of evolutionarily conserved regions within SARS-CoV-2 proteome.
Bozkus, C. C., Brown, M., Velazquez, L., Thomas, M., Wilson, E. A., O'Donnell, T., Ruchnewitz, D., Geertz, D., Bykov, Y., Kodysh, J., Oguntuyo, K. Y., Roudko, V., Hoyos, D., Srivastava, K., Kleiner, G., Alshammary, H., Karekar, N., McClain, C., Gopal, R., Nie, K., Del Valle, D., Delbeau-Zagelbaum, D., Rodriguez, D., Setal, J., The Mount Sinai COVID-19 Biobank Team, , Carroll, E., Wiesendanger, M., Gulko, P., Charney, A., Merad, M., Kim-Schulze, S., Lee, B., Wajnberg, A., Simon, V., Greenbaum, B. D., Chowell, D., Vabret, N., Luksza, M., Bhardwaj, N.
10.1101/2024.10.23.619918 — Posted: 2024-10-24
A Comprehensive Statistical Analysis of COVID-19 Trends: Global and U.S. Insights through ARIMA, Regression, and Spatial Models
LEI, Z.
10.1101/2024.10.22.24315932 — Posted: 2024-10-23
Impact of Remote Monitoring on Clinical Outcomes in Defibrillator Patients During the COVID-19 Pandemic: An Interrupted Time Series Analysis
Chand, S., Torres, B., Vickers, D., Whitten, T., Mardell, A., Sumner, G.
10.1101/2024.10.22.24315956 — Posted: 2024-10-23
National- and state-level SARS-CoV-2 immunity trends from January 2020 to December 2023: a mathematical modeling analysis
Klaassen, F., Swartwood, N., Chitwood, M. H., Lopes, R., Haraguchi, M., Salomon, J. A., Cohen, T., Menzies, N. A.
10.1101/2024.10.22.24315935 — Posted: 2024-10-23
Evaluating the Impact of Artificial Intelligence on Vaccine Development: Lessons Learned from the COVID-19 Pandemic
Farahani, A. F., Kasraei, N.
10.1101/2024.10.23.24315991 — Posted: 2024-10-23
COVID-19 Booster Doses Reduce Sex Disparities in Antibody Responses among Nursing Home Residents
Oyebanji, O. A., Yin, A., Sundheimer, N., Ragavapuram, V., Shea, P., Cao, Y., Chan, P. A., Nanda, A., Tyagi, R., Raza, S., Mujahid, N., Abul, Y., Balazs, A. B., Bosch, J., King, C. L., Klein, S., Gravenstein, S., Canaday, D. H., Wilson, B. M.
10.1101/2024.10.23.24315989 — Posted: 2024-10-23
The Incidence and Prevalence of SARS-CoV-2 in the UK Population from the UKHSA Winter COVID Infection Study
Fyles, M., Mellor, J., Paton, R., Overton, C. E., Phillips, A. M., Glaser, A., Ward, T.
10.1101/2024.10.23.24315984 — Posted: 2024-10-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).